You can help researchers improve public health by volunteering for NIAID clinical studies related to biodefense.
NIAID has a comprehensive research infrastructure with extensive resources that support all levels of biodefense and emerging infectious diseases research and pursuit of multiple broad-spectrum concepts. This infrastructure includes:
Eleven multidisciplinary research teams, based at universities nationwide, provide resources and communication systems that can be rapidly mobilized and coordinated with regional and local systems in response to an urgent public health event. These centers alone have been responsible for a vast array of research advances captured in more than 2,000 scientific publications to date.
These clinical sites, located at eight universities nationwide, allow for extensive clinical trials capacity and expertise. They played a key role in testing the vaccine for the 2009 H1N1 influenza pandemic.
These five centers, located at universities in the United States, conduct prospective international or domestic animal influenza surveillance to rapidly detect and characterize influenza viruses with pandemic potential. The centers also conduct research to enhance understanding of the molecular, ecological, or environmental factors that influence the pathogenesis, transmission, and evolution of influenza viruses; and that characterize the protective immune response.
For more information on NIAID resources and infrastructure, please see:
Last Updated December 15, 2011
Last Reviewed October 18, 2011